Table 6.2.
Heart Disease OR (95% CI) | Stroke OR (95% CI) | |||
---|---|---|---|---|
Unadjusted (n=1219±) | Adjusted£ (n=1197±) | Unadjusted (n=177±) | Adjusted£ (n=175±) | |
COC | 1.00 | 1.00 | ||
Never User | ||||
EA | 0.62 (0.42, 0.91)* | 0.64 (0.44, 0.96)* | 0.44 (0.14, 1.40) | 0.46 (0.14, 1.46) |
AA | 0.89 (0.81, 0.98)* | 0.65 (0.49, 0.87)* | 1.13 (0.64, 1.99) | 1.28 (0.72, 2.27) |
Total | 0.63 (0.51, 0.79)* | 0.65 (0.52, 0.82)* | 0.88 (0.53, 1.46) | 0.95 (0.57, 1.59) |
POC | ||||
EA | 0.95 (0.63, 1.43) | 0.74 (0.49, 1.12) | 0.25 (0.04, 1.80) | 0.19 (0.03, 1.38)¥ |
AA | 1.13 (0.82, 1.58) | 0.75 (0.53, 1.05)¥ | 0.81 (0.30, 2.22) | 0.55 (0.20, 1.50) |
Total | 1.06 (0.82, 1.37) | 0.74 (0.57, 0.97)* | 0.56 (0.23, 1.37) | 0.39 (0.16, 0.95)* |
POC+ COC | ||||
EA | 1.91 (1.46, 2.48)* | 2.07 (1.58, 2.72)* | 1.63 (0.81, 3.29) | 1.98 (0.97, 4.05)¥ |
AA | 2.36 (1.91, 2.91)* | 2.42 (1.94, 3.01)* | 1.93 (1.07, 3.48)* | 2.21 (1.22, 4.01)* |
Total | 2.16 (1.83, 2.55)* | 2.28 (1.92, 2.70)* | 1.80 (1.14, 2.82)* | 2.12 (1.34, 3.35)* |
Referent group: COC (Combined oral contraceptive); POC (Progestin-only oral contraceptive); POC+COC (Combined progestin-only method and combined oral contraceptive method); Each oral contraceptive group is mutually exclusive; EA (European American); AA (African American); Total (All Races)
Adjusted for age, years, duration of use, marital status, and education
total
Significant (p <0.05)
Borderline significant (p < 0.10)